Skip to main content
OpenTrials
Completed

NCT Number: NCT03968900

Racial Differences in Circadian and Sleep Mechanisms for Nicotine Dependence, Craving, and Withdrawal

The number one preventable cause of death in the world is tobacco use. Cigarette smoking in particular, costs an estimated $300 billion due to expenses related to medical care and lost productivity. Despite similar smoking prevalence rates, blacks suffer disproportionately from smoking-related harms compared to whites.Sleep disparities such as shortened sleep duration, shorter circadian periodicity, earlier chronotype, and increased variability of sleep timing have been reported more frequently in blacks compared to whites. Given that poor sleep quality predicts relapse from smoking cessation programs, particularly among socioeconomically disadvantaged adults, sleep deficiencies and irregular timing of sleep may impact smoking craving and withdrawal symptoms over the course of the 24-hour day. Surprisingly, few studies have examined these temporal patterns of smoking and craving, and none with regard to sleep disruption, chronotype or racial disparities. A better understanding of these factors may explain heterogeneity within the smoking population, especially in minorities. Thus, the purpose of this proposal is to test the central hypothesis that the impact of chronotype and impaired sleep on cigarette usage as well as smoking dependence, urge/craving, and withdrawal depends on race.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Alabama, Birmingham

Birmingham, Alabama, 35226, United States

About this study

Three specific aims will determine: contributions of sleep timing and sleep quality and quantity to racial disparities in smoking status (Aim 1), objective sleep characteristics and smoking behavior among blacks and whites who smoke cigarettes (Aim 2), and whether sleep restriction modifies craving and withdrawal in racially diverse smokers (Aim 3). Specifically, we will utilize self-report questionnaires, objective measures of sleep quality and timing (actigraphy) and circadian phase (dim light melatonin onset), as well as ecological momentary assessment of cigarette use, smoking urges, cravings, and withdrawal symptoms to identify circadian and sleep characteristics that are most strongly associated with smoking status, heaviness of smoking and dependence among blacks and whites. Finally, we will test whether acute sleep restriction (4 hours of time-in-bed) versus sleep extension (10 hours of time-in-bed) modifies craving and withdrawal symptoms following cessation in black and white smokers. If successful, the results of this study will result in identification of circadian dysfunction and insufficient sleep as mechanisms that underlie the association between sleep and cigarette smoking behaviors and dependence in diverse populations. Moreover, these findings are likely to inform clinicians of the importance of sleep and sleep timing on cigarette smoking behaviors and dependence that will help in the development of novel interventions to reduce morbidity and mortality caused by tobacco use.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Sub-Study 1

Inclusion criteria

  • 18 years or older
  • Able to read and speak English
  • Non-Hispanic African American (Black) or non-Hispanic white race
  • Daily smoker (5 or more cigarettes a day for the past one year and having smoked more than 100 cigarettes in lifetime) or non-smoker (smoked fewer than 100 cigarettes in a lifetime and no smoking-not even a puff- in the last year)
  • Currently residing in Alabama

Exclusion criteria

  • Non-English speaking
  • Lives in restricted environment that does not allow smoking
  • Pregnant or lactating
  • Daily or exclusive use of other tobacco products (e.g., cigars, e-cigarettes) if a smoker; if non-smoker, any other tobacco product use is exclusionary
  • Currently receiving smoking cessation treatment or using electronic cigarettes or other tobacco to try and quit smoking cigarettes
  • Participants would work outside normal 7 a.m. to 6 p.m. hours
  • Former smokers

Sub-study 2

Inclusion criteria

  • 18 years or older
  • Able to read and speak English
  • Non-Hispanic African American (Black) or non-Hispanic white race
  • Daily smoker defined as smoking 5 or more cigarettes a day for the past one year and having smoked more than 100 cigarettes in lifetime, as well as by an expired Carbon Monoxide (CO )cut-off of Carbon Monoxide (CO)>10ppm and positive cotinine test to ensure daily smoking OR non-smoker defined as smoking fewer than 100 cigarettes in a lifetime and no smoking-not even a puff- in the last year, as well as by an expired Carbon monoxide (CO) cut-off of Carbon Monoxide (CO)<3 ppm and negative cotinine test.
  • Currently residing in Alabama

Exclusion criteria

  • Non-English speaking
  • Lives in restricted environment that does not allow smoking
  • Pregnant or lactating
  • Testing positive on urine drug screen test at baseline - any drugs other than Tetrahydrocannabinol (THC) not allowed
  • Daily or exclusive use of other tobacco products (e.g., cigars, e-cigarettes) if a smoker; if non-smoker, any other tobacco product use is exclusionary
  • Currently receiving smoking cessation treatment or using electronic cigarettes or other tobacco to try and quit smoking cigarettes
  • Participants would work outside normal 7 a.m. to 6 p.m. hours
  • Former smokers
  • History of a medical condition (e.g., bipolar disorder, migraine, or seizure disorder) that might be exacerbated by sleep deprivation as a result of Study 3
  • History of a serious lung/breathing disease that prevents one from walking or holding their breath for 10 seconds (in order to complete Carbon Monoxide breath test)
  • Cognitive impairment such that participant is unable to provide informed consent
  • Acutely suicidal, manic, acutely intoxicated, or otherwise not stable enough to provide informed consent
  • Living outside of the Birmingham metro area (> 20 miles away from University of Alabama at Birmingham Main Campus)

Sub-study 3

Inclusion criteria

  • 18 years or older
  • Able to read and speak English
  • Non-Hispanic African American (Black) or non-Hispanic white race
  • Daily smoker defined as smoking 5 or more cigarettes a day for the past one year and having smoked more than 100 cigarettes in lifetime, as well as by an expired Carbon Monoxide (CO) cut-off of Carbon Monoxide (CO)>10ppm and positive cotinine test to ensure daily smoking
  • Currently residing in Alabama

Exclusion criteria

  • Non-English speaking
  • Lives in restricted environment that does not allow smoking
  • Pregnant or lactating
  • Daily or exclusive use of other tobacco products (e.g., cigars, e-cigarettes) if a smoker; if non-smoker, any other tobacco product use is exclusionary
  • Currently receiving smoking cessation treatment or using electronic cigarettes or other tobacco to try and quit smoking cigarettes
  • Participants would work outside normal 7 a.m. to 6 p.m. hours
  • Former smokers
  • History of a medical condition (e.g., bipolar disorder, migraine, or seizure disorder) that might be exacerbated by sleep deprivation as a result of Study 3
  • Currently taking any psychiatric medications, pain medications (i.e., opioids), or sleep medications (e.g., Ambien, trazodone, melatonin pills, Cannabidiol (CBD) products)
  • History of a serious lung/breathing disease that prevents one from walking or holding their breath for 10 seconds
  • Testing positive on urine drug screen test at baseline - any drugs other than Tetrahydrocannabinol (THC) not allowed
  • Has an apnea-hypopnea index (AHI) score of > 15 on home sleep testing that was conducted during sub-study 2
  • Uses Continuous positive airway pressure (CPAP) machine to sleep at night
  • Cognitive impairment such that participant is unable to provide informed consent
  • Acutely suicidal, manic, acutely intoxicated, or otherwise not stable enough to provide informed consent
  • Living outside of the Birmingham metro area (> 20 miles away from University of Alabama at Birmingham Main Campus)

Treatment and study plan

Sleep restriction condition

Behavioral

On day 1, participants will complete study assessments and will be fitted with an Actiwatch and instructed to continue a fixed time in bed (8 hours duration with no more than 20 min deviation) centered on habitual sleep (e.g., 11:00 p.m. to 7:00 a.m.). Naps will not be allowed. Following the one-week baseline sleep stabilization, participants will engage in the sleep restriction condition (4 hours, TIB [Time in Bed]; 1:00 a.m. to 5:00 a.m.). On the day of each sleep study, participants will be admitted to University of Alabama Birmingham (UAB) Highlands Hospital sleep unit at 7:00 p.m. and do an initial CO breathe test and fill out study questionnaires and a timeline follow-back procedure Participants will monitored for smoking withdrawal. Every 2 hours, participants to fill out various questionnaires. Participants will repeat the same conditions as the first night. After a two-week washout, participants will be crossed over to the alternate sleep extension/restriction condition.

Sleep extension condition

Behavioral

sleep extension On day 1, participants will complete study assessments and will be fitted with an Actiwatch and instructed to continue a fixed time in bed (8 hours duration with no more than 20 min deviation) centered on habitual sleep (e.g., 11:00 p.m. to 7:00 a.m.). Naps will not be allowed. Following the one-week baseline sleep stabilization, participants will engage in the sleep extension condition (10 hours, (TIB); 10:00 p.m. to 8:00 a.m.). On the day of each sleep study, participants will be admitted to University of Alabama Birmingham Highlands Hospital sleep unit at 7:00 p.m. and do an initial CO breathe test and fill out study questionnaires and a timeline follow-back procedure Participants will monitored for smoking withdrawal. Every 2 hours, participants to fill out various questionnaires. Participants will repeat the same conditions as the first night. After a two-week washout, participants will be crossed over to the alternate sleep extension/restriction condition.

Primary outcomes

  1. Sleep Hygiene Index

    Time frame: 1 day at baseline

    A 13-item scale that assesses behaviors, such as variability in wake-time, timing of physical activity, and substance use, that comprise sleep hygiene. Higher values indicate worse sleep hygiene. The minimum value is 0, and the maximum value is 52.

Secondary outcomes

  1. Pittsburgh Sleep Quality Index

    Time frame: 1 day at baseline

    A 7-item self-report measure that assesses global sleep quality over the past month. Additionally, sub-scales that include duration of sleep, sleep disturbance, sleep latency, daytime dysfunction, sleep efficiency, and dependence on hypnotic medication may be calculated from individual items. Higher scores indicate worse sleep quality. The minimum score is 0, and the maximum score is 21.

  2. Munich Chronotype Questionnaire

    Time frame: 1 day at baseline

    Questionnaire that determines chronotype from midsleep time calculated from sleep onset and offset on both free days and work days. Chronotype will be determined from the mid-sleep time on days off. Specifically, Mid-sleep time is equal to Sleep onset + Sleep duration/2. For those who sleep longer on days off than on workdays, we will correct for weekend recovery sleep by subtracting 'sleep debt' accumulated, which is estimated by the following equation: Sleep duration on free days - Sleep duration (average) for the week/2. Chronotype is the participant's midsleep time on free days. Higher values indicate that midsleep time is later in the day. The minimum value is 0, and the maximum value is 24.

  3. Fagerström Test for Nicotine Dependence

    Time frame: 1 day at baseline

    A 6-item self-report measure of nicotine dependence derived from the Fagerström Tolerance Questionnaire. Higher scores indicate greater nicotine dependence. The minimum value is 1, and the maximum value is 10.

  4. Snoring History, Tired During the Day, Observed Stop Breathing While Sleep, High Blood Pressure, BMI More Than 35 kg/m2, Age More Than 50 Years, Neck Circumference More Than 40 cm and Male Gender (STOP-BANG) Questionnaire

    Time frame: 1 day at baseline

    A 8-item self-report questionnaire that assesses the primary risk factors for obstructive sleep apnea to create a total score that ranges from 0 to 8. Higher scores indicate greater risk of sleep apnea.

  5. Insomnia Severity Index

    Time frame: 1 day at baseline

    A 7-item self-report questionnaire that assesses the severity of core symptoms of insomnia over the previous 2 weeks. Higher scores indicate more severe insomnia. The minimum score is 0, and the maximum score is 28.

  6. Dysfunctional Beliefs and Attitudes About Sleep (DBAS)

    Time frame: 1 day at baseline

    A 16-item questionnaire that assesses beliefs about sleep and the consequences of poor sleep. Higher scores indicate more dysfunctional beliefs about sleep. The minimum score is 0, and the maximum score is 10.

  7. Epworth Sleepiness Scale (ESS)

    Time frame: 1 day at baseline

    A 8-item questionnaire that asks individuals to rate their "chances of dozing off" on a scale of 0 (never) to 3 (high) in eight different situations. The scores are summed to create a total score with higher values indicating higher chances of dozing off. The minimum score is 0, and the maximum score is 24.

  8. Everyday Discrimination Scale (EDS)

    Time frame: 1 day at baseline

    This 9-item assessment queries about experiences of discrimination such as being treated less respectfully or people thinking that you are dishonest. Responses range from "almost every day" to "never." Higher score indicate more ways that discrimination was experienced. The minimum score is 0, and the maximum score is 9.

  9. Perceived Stress Scale - 10 Item (PSS-10)

    Time frame: 1 day at baseline

    Self-report questionnaire that assesses a person's perceived stress with a 5-point Likert scale ranging from "Never" to "Very Often." Higher scores indicate greater levels of perceived stress. The minimum score is 0, and the maximum score is 40.

Other outcomes

  1. Duke- The University of North Carolina at Chapel Hill (UNC) Functional Social Support Questionnaire (FSSQ)

    Time frame: 1 day at baseline

    A 8-item 1-5 Likert scale ranging from "much less than I would like" to "as much as I would like" that measures perceived social support. Higher scores indicate greater social support. The minimum score is 1, and the maximum score is 40.

  2. Patient Health Questionnaire (PHQ-9)

    Time frame: 1 day at baseline

    A 9-item instrument that measures severity of depression as well as the presence of suicide ideation. Higher scores indicate more sever symptoms of depression. The minimum score is 0, and the maximum score is 27.

  3. Generalized Anxiety Disorder (GAD-7)

    Time frame: 1 day at baseline

    A 7-item anxiety scale used to identify probable cases of generalized anxiety disorder. Higher scores indicate more severe symptoms of anxiety. The minimum score is 0, and the maximum score is 28.

  4. Assessing Smoking History

    Time frame: 1 day at baseline

    Smoking history will be assessed for daily smokers as smoking 5 or more cigarettes a day for the past one year and having smoked more than 100 cigarettes in lifetime or non-smoker defined as smoking fewer than 100 cigarettes in a lifetime and no smoking-not even a puff- in the last year. Using those definitions, we determined the number of participants who were smokers.

  5. Brief Wisconsin Inventory of Smoking Dependence Motives (WISDM-37)

    Time frame: 1 day at baseline

    The WISDM measures how strongly participants feel 11 potential motivations for smoking. Higher scores indicate being more strongly motivated to smoke. The minimum score is 11, and the maximum score is 77.

  6. Tobacco Craving Questionnaire-SF (TCQ-SF)

    Time frame: 1 day at baseline

    The TCQ-SF contains 12 items to assess participants' craving to smoke cigarettes. Higher scores indicate stronger craving for tobacco. The minimum score is 12, and the maximum score is 84.

  7. Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST)

    Time frame: 1 day at baseline

    The ASSIST asks questions assessing level of dependence to 10 different substances. Higher scores indicate more negative impacts of substance use. the minimum score is 0, and the maximum score is 280.

  8. Minnesota Nicotine Withdrawal Scale (MNWS).

    Time frame: 1 day at baseline

    The MNWS is an 8-item measure designed to assess Smokers' cigarette withdrawal in the last 24 hours. Higher scores indicate more severe symptoms of nicotine withdrawal. The minimum score is 0, and the maximum score is 32.

  9. Alcohol Use Disorders Identification Test-Consumption (AUDIT-C).

    Time frame: 1 day at baseline

    A brief 3-item alcohol screening measure that identifies hazardous drinkers or those who have active alcohol use disorders. Higher scores indicate more symptoms of alcohol use disorder. The minimum score is 0, and the maximum score is 12.

  10. Pain, Enjoyment, General Activity (PEG) Scale

    Time frame: 1 day at baseline

    The PEG Scale contains 3 questions regarding how much pain has interfered with enjoyment of life and general activity in the past 7 days. Higher scores indicate greater interference from pain. The minimum score is 0, and the maximum score is 10.

  11. Trauma History Scale (THS)

    Time frame: 1 day at baseline

    The THS is a brief 14-item self-report measure designed to assess traumatic events and how much those events are emotionally bothersome. The scale counts the number of traumas endorsed. The minimum value is 0, and the maximum value is 14.

  12. PTSD Checklist-Short Form (PCL-5)

    Time frame: 1 day at baseline

    The short form of the 20-item PCL-5 which assesses the presence and severity of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for PTSD in the past month. The short form contains 4 items. Higher scores indicate more sever symptoms of PTSD. The minimum score is 0, and the maximum score is 16.

  13. International Consultation on Incontinence Questionnaire-Overactive Bladder

    Time frame: 1 day at baseline

    4 items pertaining to overactive bladder symptoms experienced in the past 4 weeks. Higher scores indicate more symptoms of overactive bladder. The minimum score is 0, and the maximum score is 16.

  14. International Physical Activity Questionnaire (IPAQ)

    Time frame: 1 day at baseline

    A set of questionnaires designed to assess physical activity and sedentary lifestyles. The questionnaire measures the minutes of physical activity per week, weighted by the intensity of the activity, referred to as the MET-min. The minimum value is 0, and a value that indicates high levels of activity per week would be 3000.

  15. Standard Shiftwork Index (SSI)

    Time frame: 1 day at baseline

    A battery of self-report questionnaires measuring shift workers' sleep and stress outcomes. We are using the physical health subsections of this questionnaire. The scale counts the number of physical conditions endorsed. The minimum score is 0, and the maximum score is 23.

  16. Fatigue Severity Scale (FSS)

    Time frame: 1 day at baseline

    A 9-item scale measuring severity of fatigue and its effect on participants' activities and lifestyle. Higher scores indicate more severe fatigue. The minimum score is 9, and the maximum score is 63.

  17. Assessing Continuous Positive Airway Pressure (CPAP) Use

    Time frame: 1 day at baseline

    A 5-item survey designed by the research team to assessed whether or not participants are prescribed CPAP, and their adherence to using it. Using that questionnaire, we determined the number of participants who used a CPAP.

Sponsors and collaborators

Lead sponsor

University of Alabama at Birmingham

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)
  • University of Oklahoma

Registry information

Important dates

Study start
2021
Primary completion
2025
Study completion
2025
First posted
May 30, 2019
Registry last updated
Jul 31, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.